Decoy Therapeutics Inc. Other Current Liabilities
Decoy Therapeutics Inc. (DCOY) had Other Current Liabilities of $2.31 thousand as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-03-31
- 2025-12-31: Other Liabilities, Current $2.31K.
- 2024-12-31: Other Liabilities, Current $0.00.
| Period end | Other Liabilities, Current |
|---|---|
| 2025-12-31 | $2.31K 10-K · filed 2026-03-31 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |